Breast Cancer Trial, Recruiting NCT04069884 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT04069884
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old.
  • You are reasonably active and able to care for yourself, even if you cannot do heavy physical work (confirm with trial site regarding fitness level assessment).
  • After surgery, your tissue sample clearly confirmed you have invasive breast cancer.
  • Your cancer is considered "low risk" based on specific features of how far it has spread to nearby lymph nodes, your age, and the type of breast cancer you have (confirm with trial site for full details).
  • The cancer in your lymph nodes under the arm falls into one of these categories: tiny amounts of cancer cells found (micrometastasis), 1–2 lymph nodes affected found during a sentinel node biopsy, or 1–3 lymph nodes affected found during more extensive lymph node removal.
  • You had surgery to either remove the whole breast (with or without reconstruction) or just the tumor area (breast-conserving surgery).
  • Within the last 3 months before starting radiotherapy, scans and tests confirmed the cancer has not spread to other parts of your body.
  • Within the last 12 months before starting radiotherapy, a mammogram and/or MRI confirmed no cancer in your other breast.
  • You have completed at least 4 rounds of chemotherapy after surgery using specific drug types (anthracycline or taxane), unless a special gene test showed your cancer was low risk and chemotherapy could be safely skipped.
  • Your radiotherapy is planned to start no later than 8 weeks after finishing chemotherapy.
  • Enough tissue samples from your surgery are available for a specific genetic test called RecurIndex.
  • You have not had any other cancer in the past, except for a type of non-serious skin cancer called basal cell carcinoma.
  • You have read and signed a consent form agreeing to take part in the trial.

Who may not be able to join:

  • Your cancer has been classified at a more advanced stage (T3–4, N0, N2–3, or M1) before joining the trial.
  • You received any treatment before surgery, such as chemotherapy, hormone therapy, targeted therapy, or radiotherapy.
  • You had your whole breast removed but only had a sentinel lymph node biopsy (without more extensive lymph node removal).
  • You have had breast cancer in your other breast at any point in the past.
  • You have previously had radiotherapy to your chest area.
  • You have a serious existing condition affecting your heart, lungs, liver, kidneys, blood, nervous system, or mental health.
  • You have a history of certain autoimmune diseases, such as scleroderma or active lupus.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8613556080080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
20 August 2019
Est. completion
20 August 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Invasive disease-free survival (IDFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov